Načítá se...
Defining and Targeting the Oncogenic Drivers of Neuroendocrine Prostate Cancer
In this issue of Cancer Cell, Lee and colleagues (2016) define the biologic role of MYCN in promoting prostate tumorigenesis and development of a neuroendocrine phenotype. This has important implications for the clinical management of neuroendocrine prostate cancer as Aurora A kinase inhibitors prom...
Uloženo v:
| Vydáno v: | Cancer Cell |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5550814/ https://ncbi.nlm.nih.gov/pubmed/27070695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2016.03.023 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|